Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report.

Koichi SugiharaRisa WakiyaHiromi ShimadaMikiya KatoTomohiro KamedaShusaku NakashimaMai Mahmoud Fahmy MansourYusuke UshioNorimitsu KadowakiHiroaki Dobashi

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2021)

Our results suggest that increased interleukin-6 levels in the blood following tocilizumab treatment may be linked to development of interstitial lung disease.

Keyphrases

juvenile idiopathic arthritis
interstitial lung disease
systemic sclerosis
rheumatoid arthritis
disease activity
idiopathic pulmonary fibrosis
low dose
case report
rheumatoid arthritis patients
replacement therapy